Cutler Group LP Solid Biosciences Inc. Put Options Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2020 Jul 22, 2020	SELL	$2.1 - $3.42 $6,300 - $10,260	-3,000 Reduced 75.0%	1,000 $1,000
Q1 2020 May 07, 2020	SELL	$2.31 - $4.43 $462 - $886	-200 Reduced 4.76%	4,000 $33,000
Q4 2019 Feb 06, 2020	BUY	$2.82 - $12.9 $10,716 - $49,020	3,800 Added 950.0%	4,200 $26,000
Q3 2019 Oct 28, 2019	SELL	$4.33 - $11.64 $5,196 - $13,968	-1,200 Reduced 75.0%	400 $0
Q1 2019 May 10, 2019	BUY	$7.19 - $32.37 $10,785 - $48,554	1,500 Added 1500.0%	1,600 $6,000
Q4 2018 Feb 05, 2019	BUY	$21.32 - $46.34 $2,132 - $4,634	100 New	100 $0

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $53.2M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.